It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

The survey of 1,078 adults, carried out by Ipsos, found 24% of people would use weight-loss jabs if they were provided for ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

However, while Wegovy is prescribed by the NHS for weight management, Rybelsus is not licensed for such and is only available as a treatment for Type 2 diabetes. There are other limitations too. In ...

The new results are from a phase 1 trial of a once-daily pill called CT-966 ... Novo Nordisk's oral formulation of semaglutide for diabetes – Rybelsus – needs to be dosed in the fasting ...

The 50 mg oral semaglutide pill achieved a 15.1% ... Oral semaglutide is already sold as Rybelsus in a 14 mg formulation for the treatment of type 2 diabetes, bringing in sales of $1.6 billion ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Study estimates 136.8 million U.S. adults are eligible for semaglutide, a popular therapy for diabetes, weight loss, and cardiovascular disease.

With over 101 million Indians estimated to be suffering from diabetes and another 136 million at the pre-diabetes stage, as per the Indian Council for Medical Research (ICMR), there is an urgent ...

Chavan went from needing two daily insulin shots to a quarter of a diabetes pill. Dr Bandgar said remission is usually seen in patients with diabetes for less than a decade. "But due to his ...